Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eric R. A. Vos"'
Autor:
Cheyenne C. E. van Hagen, Anne J. Huiberts, Elizabeth N. Mutubuki, Hester E. de Melker, Eric R. A. Vos, Janneke H. H. M. van de Wijgert, Susan van den Hof, Mirjam J. Knol, Albert Jan van Hoek
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/b7b4db10222d4b8f903fc470b90f3add
Autor:
Jantien A. Backer, Laurens Bogaardt, Philippe Beutels, Pietro Coletti, W. John Edmunds, Amy Gimma, Cheyenne C. E. van Hagen, Niel Hens, Christopher I. Jarvis, Eric R. A. Vos, James Wambua, Denise Wong, Kevin van Zandvoort, Jacco Wallinga
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The COVID-19 pandemic was in 2020 and 2021 for a large part mitigated by reducing contacts in the general population. To monitor how these contacts changed over the course of the pandemic in the Netherlands, a longitudinal survey was conduct
Externí odkaz:
https://doaj.org/article/8021197268ab464e907eb4ca744dc8b2
Autor:
Lotus L. van den Hoogen, Marije K. Verheul, Eric R. A. Vos, Cheyenne C. E. van Hagen, Michiel van Boven, Denise Wong, Alienke J. Wijmenga-Monsuur, Gaby Smits, Marjan Kuijer, Debbie van Rooijen, Marjan Bogaard-van Maurik, Ilse Zutt, Jeffrey van Vliet, Janine Wolf, Fiona R. M. van der Klis, Hester E. de Melker, Robert S. van Binnendijk, Gerco den Hartog
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract mRNA- and vector-based vaccines are used at a large scale to prevent COVID-19. We compared Spike S1-specific (S1) IgG antibodies after vaccination with mRNA-based (Comirnaty, Spikevax) or vector-based (Janssen, Vaxzevria) vaccines, using sam
Externí odkaz:
https://doaj.org/article/162a4ca5e4c94aa78dc88a306bb74af7
Autor:
Eric R. A. Vos, Guido E.L. van den Berk, Lea M. Dijksman, Anja Leyte, Mihai G. Netea, Ineke W. E. M. Schouten, Jos P. H. J. Frissen, Robyn G. M. Weijma, Kees Brinkman, Muriel van Schilfgaarde, W.L. Blok, André J. A. M. van der Ven, Jaap ten Oever
Publikováno v:
Open Forum Infectious Diseases, 3, ofv201
Open Forum Infectious Diseases, 3, 1, pp. ofv201
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 3, 1, pp. ofv201
Open Forum Infectious Diseases
Background. Immune activation has been implicated in the excess mortality in human immunodeficiency virus (HIV)-infected patients, due to cardiovascular diseases and malignancies. Statins may modulate this immune activation. We assessed the capacity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::322179682421998115d1947a2fe198f6
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/165801
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/165801
Autor:
Jantien A. Backer, Laurens Bogaardt, Philippe Beutels, Pietro Coletti, W. John Edmunds, Amy Gimma, Cheyenne C. E. van Hagen, Niel Hens, Christopher I. Jarvis, Eric R. A. Vos, James Wambua, Denise Wong, Kevin van Zandvoort, Jacco Wallinga
Publikováno v:
Scientific reports
The COVID-19 pandemic was in 2020 and 2021 for a large part mitigated by reducing contacts in the general population. To monitor how these contacts changed over the course of the pandemic in the Netherlands, a longitudinal survey was conducted where
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b0db833a6d2a4ad3dc2801aa77a08a